Showing results (481-490 of 2,294) with videos related to

Sort By:
Pageof 230
Cancer Research and Treatment|November 8, 2024
Fraction of Cancer Attributable to Carcinogenic Drugs in Korea from 2015 to 2030Woojin Lim, Soseul Sung, Youjin Hong, et al.
Cancer Research and Treatment|November 8, 2024
Low‒Dose Cyclophosphamide Enhances the Tumoricidal Effects of 5-Day Spacing Stereotactic Ablative Radiotherapy by Boosting Antitumor ImmunityHyunkyung Kim, Seok-Joo Chun, Sojung Sun, et al.
Cancer Research and Treatment|November 20, 2024
Effectiveness and Safety of Regorafenib and TAS-102 in Patients with Metastatic Colorectal Cancer: A Nationwide Population-Based Study in TaiwanYa-Wen Chang, Chun-Nan Kuo, Chia-Lun Chang, et al.
Cancer Research and Treatment|November 20, 2024
Association of Pro-inflammatory Cytokines with Gastric Cancer Risk: A Case-Cohort StudySeungju Baek, Eunjung Park, Eun Young Park
Cancer Research and Treatment|November 20, 2024
Machine Learning-Based Prognostic Gene Signature for Early Triple Negative Breast CancerJu Won Kim, Jonghyun Lee, Sung Hak Lee, et al.
Cancer Research and Treatment|March 14, 2025
Pilot Study for Feasibility of Onco-Geriatric Intervention Model in Older Patients with Cancer in a Tertiary Academic HospitalJin Won Kim, Jung-Yeon Choi, Woochan Park, et al.
Cancer Research and Treatment|August 9, 2024
Combination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 StudyChunfang Hao, Xu Wang, Yehui Shi, et al.
Cancer Research and Treatment|August 2, 2024
Integrating Deep Learning-Based Dose Distribution Prediction with Bayesian Networks for Decision Support in Radiotherapy for Upper Gastrointestinal CancerDong-Yun Kim, Bum-Sup Jang, Eunji Kim, et al.
Cancer Research and Treatment|June 28, 2024
Enhancing Identification of High-Risk cN0 Lung Adenocarcinoma Patients Using MRI-Based Radiomic FeaturesHarim Kim, Jonghoon Kim, Soohyun Hwang, et al.
Cancer Research and Treatment|July 12, 2024
A Single-Arm Phase II Clinical Trial of Fulvestrant Combined with Neoadjuvant Chemotherapy of ER+/HER2- Locally Advanced Breast Cancer: Integrated Analysis of 18F-FES PET-CT and Metabolites with Treatment ResponseQing Shao, Ningning Zhang, Xianjun Pan, et al.
Pageof 230